Reinhard J. Ambros, Ph.D.

October 2, 2019

Reinhard Ambros has served as a member of our board of directors since June 2013. Dr. Ambros retired from Novartis Venture Funds after serving as global head from August 2005 until September 2017. He previously served as head of group strategic planning for Novartis AG, a multinational pharmaceutical company, from 2001 until 2005, and as global head of business development and licensing for cardiovascular and metabolic diseases at Novartis Pharma AG. Dr. Ambros received an M.S. from the University of Regensburg, Germany, and a Ph.D. in medicinal chemistry and pharmacology from the University of Regensburg, Germany.